🇺🇸 pentoxifylline (PTX) in United States

FDA authorised pentoxifylline (PTX) on 30 August 1984

Marketing authorisation

FDA — authorised 30 August 1984

  • Application: NDA018631
  • Marketing authorisation holder: VALIDUS PHARMS
  • Local brand name: TRENTAL
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is pentoxifylline (PTX) approved in United States?

Yes. FDA authorised it on 30 August 1984.

Who is the marketing authorisation holder for pentoxifylline (PTX) in United States?

VALIDUS PHARMS holds the US marketing authorisation.